Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 2/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30203909 | 1.00 | BRD4 (0.31) | BRD4CREBBPNPC1LMNATP53 | |
| Hydrochloric Acid SCHEMBL31746177 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL3617320 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL31099218 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL3685625 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL8457636 | 0.89 | KDR (0.32) | KIF11 | |
| Hydrochloric Acid SCHEMBL31255988 | 0.88 | KIF11 (0.37) | KIF11 | |
| Hydrochloric Acid SCHEMBL2234561 | 0.87 | SYK (0.30) | — | |
| Fluoride Ion SCHEMBL1131093 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL216306 | 0.85 | PDCD1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1799726-B1 | TRIALKYLALUMINUM TREATED SUPPORTS | EXXONMOBIL CHEM PATENTS INC (US) | 2011-07-13 | — | — | EP | claimed |
| US-7741417-B2 | Preparation of polymerization catalyst activators utilizing indole-modified silica supports | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-06-22 | — | — | US | claimed |
| US-7385015-B2 | Trialkylaluminum treated supports | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-06-10 | — | — | US | claimed |
| EP-1799726-A1 | TRIALKYLALUMINUM TREATED SUPPORTS | Exxonmobil Chemical Patents Inc. (US) | 2007-06-27 | — | — | EP | claimed |
| US-7220695-B2 | Supported activator | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-22 | — | — | US | claimed |
| US-20070055028-A1 | Preparation of polymerization catalyst activators utilizing indole-modified silica supports | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-03-08 | — | — | US | claimed |
| WO-2006044058-A1 | TRIALKYLALUMINUM TREATED SUPPORTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-04-27 | — | — | WO | claimed |
| US-10676547-B2 | Aluminum alkyls with pendant olefins on clays | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-06-09 | — | — | US | disclosed |
| EP-2064248-B1 | PREPARATION OF POLYMERIZATION CATALYST ACTIVATORS UTILIZING INDOLE-MODIFIED SILICA SUPPORTS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20180201700-A1 | Aluminum Alkyls with Pendant Olefins on Clays | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-07-19 | — | — | US | disclosed |
| EP-1858934-B1 | METALLOCENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-1709085-B1 | SUPPORTED ACTIVATOR FOR POLYMERISATION CATALYST | EXXONMOBIL CHEM PATENTS INC (US) | 2013-03-20 | — | — | EP | disclosed |
| EP-1799726-B1 | TRIALKYLALUMINUM TREATED SUPPORTS | EXXONMOBIL CHEM PATENTS INC (US) | 2011-07-13 | — | — | EP | disclosed |
| EP-1664137-A1 | MULTISTEP PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | Basell Polyolefine GmbH (DE) | 2006-06-07 | — | — | EP | disclosed |
| EP-1664140-A1 | MULTISTEP PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | Basell Polyolefine GmbH (DE) | 2006-06-07 | — | — | EP | disclosed |
| WO-2006044058-A1 | TRIALKYLALUMINUM TREATED SUPPORTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20060020096-A1 | Transition metal compound, ligand system, catalyst system and its use for the polymerization and copolymerization of olefins | SCHOTTEK JORG | 2006-01-26 | — | — | US | disclosed |
| WO-2005023889-A1 | MULTISTEP PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | BASELL POLYOLEFINE GMBH (DE) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005023892-A1 | MULTISTEP PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | BASELL POLYOLEFINE GMBH (DE) | 2005-03-17 | — | — | WO | disclosed |
| US-20030149199-A1 | Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins | BASELL POLYPROPYLEN GMBH (DE) | 2003-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149199-A1 | Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins | PORCN, PGR, PPOX | BRD4 1223/4885CREBBP 2360/4885NPC1 4292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.